Fibrinogen Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Fibrinogen market size was valued at USD 819.7 million in 2022 and is forecast to a readjusted size of USD 2133.3 million by 2029 with a CAGR of 14.6% during review period.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

This report is a detailed and comprehensive analysis for global Fibrinogen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Fibrinogen market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Fibrinogen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Fibrinogen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Fibrinogen market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/g), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fibrinogen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Fibrinogen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   CSL Behring
   LFB Group
   Shanghai RAAS Blood Products
   Jiangxi Boya Bio-Pharmaceutical
   Hualan Biological Engineering
   Harbin Pacific Biopharmaceutical
   GREEN CROSS
   Shanghai XinXing Medical
   Taibang Biologic
   Octapharma

   Human Fibrinogen
   Animal Fibrinogen

   Congenital Fibrinogen Deficiency
   Surgical Procedures
   Others

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the fibrinogen market in 2025?

The fibrinogen market is driven by its increasing demand for various therapeutic applications, including bleeding disorders and surgeries. Advancements in biotechnology and improved diagnostic tools also play a major role in strengthening the market.

How about the weaknesses of the fibrinogen market?

A key weakness is the high cost of fibrinogen-based therapies, which can limit accessibility, particularly in low-income regions. Additionally, there is a risk of market fragmentation with varying regulatory standards and the challenge of producing fibrinogen at a scalable, consistent quality.

What are the opportunities in the fibrinogen market by 2025?

There are significant opportunities in expanding fibrinogen usage in emerging markets where healthcare infrastructure is improving. Also, growing research into personalized medicine and novel fibrinogen-based treatments offers substantial growth potential for the market.

What are the threats to the fibrinogen market in 2025?

Rising competition from synthetic and alternative clotting factor products could threaten the market. Furthermore, regulatory challenges and potential safety concerns with fibrinogen therapies may hinder growth. Lastly, economic fluctuations and cost-cutting measures in healthcare could negatively impact demand.

What are the political factors influencing the fibrinogen market in 2025?

Government policies and regulations regarding the approval and use of therapeutic products play a significant role in shaping the market. Additionally, public healthcare funding and support for bleeding disorder treatments will impact the accessibility and growth of the fibrinogen market.

How do economic factors affect the fibrinogen market?

Economic factors such as healthcare budgets, the affordability of therapies, and disposable income will impact the market. In regions with economic downturns or cost-cutting healthcare measures, demand for fibrinogen therapies could be affected, limiting market growth.

What are the social factors impacting the fibrinogen market?

Growing awareness of bleeding disorders and better healthcare education can drive the demand for fibrinogen therapies. An aging population with increasing surgical procedures and chronic conditions also contributes to higher demand for fibrinogen-based treatments.

What technological factors are influencing the fibrinogen market?

Advancements in biotechnology, such as improved manufacturing techniques for fibrinogen, contribute to a more efficient production process and better product consistency. Innovations in diagnostic tools for detecting bleeding disorders also boost the need for fibrinogen products.

How do environmental factors play a role in the fibrinogen market?

Environmental concerns around the production and disposal of biological products could impact market growth. Stricter environmental regulations on pharmaceutical production and sustainable sourcing of materials could raise production costs but could also create opportunities for eco-friendly innovations.

What legal factors are affecting the fibrinogen market?

Regulatory standards for drug approval and patent laws are critical in shaping the fibrinogen market. Legal issues related to intellectual property rights and product liability could affect market dynamics and competition, influencing the pricing and availability of therapies.

Who are the suppliers in the fibrinogen market in 2025?

Suppliers in the fibrinogen market include pharmaceutical manufacturers, biotechnological companies, and raw material suppliers who provide plasma or recombinant proteins needed for fibrinogen production.

Who are the inputs in the fibrinogen market?

Inputs include raw materials like human plasma or synthetic substitutes, specialized manufacturing technologies, skilled labor, and regulatory approval documentation required to produce and distribute fibrinogen products.

What are the processes involved in the fibrinogen market?

The processes include research and development for innovative fibrinogen treatments, manufacturing and purification of fibrinogen, regulatory approval processes, distribution to healthcare providers, and continuous post-market surveillance for safety and efficacy.

Who are the customers in the fibrinogen market?

Customers in the fibrinogen market include hospitals, clinics, pharmaceutical companies, healthcare providers, and patients suffering from bleeding disorders, surgical patients, and those requiring fibrinogen-based treatments for other medical conditions.

What are the outputs in the fibrinogen market?

Outputs are high-quality fibrinogen products used in medical treatments, therapies for bleeding disorders, surgical procedures, and emergency care, as well as innovations in recombinant and plasma-derived fibrinogen therapies.

What is the threat of new entrants in the fibrinogen market in 2025?

The threat of new entrants is moderate. While the market holds potential, the high barriers to entry—such as the need for significant capital investment, advanced technology, and regulatory approvals—limit the entry of new competitors.

How intense is the bargaining power of suppliers in the fibrinogen market?

The bargaining power of suppliers is moderate. While there are a limited number of suppliers providing raw materials like plasma, the increasing use of recombinant technologies and alternatives helps to balance supplier power.

What is the bargaining power of buyers in the fibrinogen market?

The bargaining power of buyers is relatively low. The specialized nature of fibrinogen products for treating life-threatening conditions reduces the ability of buyers to negotiate prices, especially given the limited alternatives in treatment.

What is the threat of substitute products in the fibrinogen market?

The threat of substitutes is moderate. While there are alternatives such as synthetic clotting factors and recombinant therapies, fibrinogen remains a preferred treatment for specific conditions, although advancements in substitutes could impact market share.

How intense is the rivalry among existing competitors in the fibrinogen market?

Rivalry among existing competitors is high. The market is dominated by a few key players who compete for market share, particularly through price, product differentiation, and technological advancements in fibrinogen production.

What are the key raw materials for the fibrinogen market in 2025?

The key raw materials for the fibrinogen market include human plasma, recombinant proteins, and advanced biotechnological resources for synthesizing fibrinogen. The quality and availability of these materials are crucial for production.

How do suppliers impact the fibrinogen market?

Suppliers play a critical role in providing high-quality plasma and recombinant proteins, both of which are essential for producing fibrinogen. The reliability of suppliers and their ability to maintain consistent supply chains impact the overall production and availability of fibrinogen products.

What are the challenges in the upstream supply chain for the fibrinogen market?

Challenges in the upstream supply chain include maintaining the quality and safety of raw materials, the high cost of plasma collection, regulatory hurdles for plasma-derived products, and the complexity of scaling recombinant protein production to meet demand.

How do technological advancements affect the upstream part of the fibrinogen market?

Technological advancements, particularly in recombinant DNA technology and purification processes, have greatly improved the efficiency and safety of fibrinogen production. These innovations help reduce dependency on plasma and improve the consistency of the final product.

How do regulations influence the upstream supply chain in the fibrinogen market?

Regulations significantly impact the upstream supply chain, as stringent standards for plasma collection, blood safety, and recombinant protein production are enforced. Compliance with these regulations ensures the safety and efficacy of the final product, but also increases costs and complexity in the upstream process.

What are the key activities in the midstream phase of the fibrinogen market?

The key activities in the midstream phase include the processing, refining, and manufacturing of fibrinogen products from raw materials. This involves extraction from plasma or recombinant processes, purification, and ensuring the products meet regulatory standards for safety and efficacy.

How do manufacturers impact the fibrinogen market?

Manufacturers are critical in the midstream phase as they are responsible for converting raw materials into usable fibrinogen products. Their ability to scale production, innovate in technology, and ensure product quality directly affects the availability and pricing of fibrinogen therapies.

What are the challenges faced during the midstream production of fibrinogen?

Challenges during midstream production include maintaining consistent product quality, meeting regulatory requirements, and managing production costs. Ensuring the safety and purity of fibrinogen products while scaling up production to meet global demand can also be challenging.

How do technological advancements influence the midstream process in the fibrinogen market?

Technological advancements, particularly in biomanufacturing and recombinant protein technologies, improve the efficiency and scalability of fibrinogen production. These innovations help reduce costs, increase yield, and enhance the overall quality of the products.

How do regulatory standards impact the midstream phase of the fibrinogen market?

Regulatory standards heavily influence the midstream phase, as manufacturers must comply with stringent guidelines on product quality, safety, and efficacy. These regulations ensure that fibrinogen therapies meet required health standards but also add complexity and costs to the manufacturing process.

What are the key activities in the downstream phase of the fibrinogen market?

The key activities in the downstream phase involve the distribution and delivery of fibrinogen products to hospitals, clinics, and patients. This phase also includes post-market surveillance, sales, and ensuring the proper storage and handling of the product.

How do distributors and healthcare providers impact the fibrinogen market?

Distributors and healthcare providers are essential in ensuring that fibrinogen products reach the end users. They manage the logistics of product availability and ensure that patients have access to necessary treatments, impacting market penetration and patient outcomes.

What challenges exist in the downstream phase of the fibrinogen market?

Challenges in the downstream phase include managing the cold chain logistics for storing fibrinogen products, meeting regional regulatory requirements for distribution, and ensuring access to fibrinogen therapies in remote or underdeveloped areas.

How do patient demand and awareness influence the downstream market for fibrinogen?

Patient demand and awareness significantly impact the downstream market. As awareness of bleeding disorders increases and as healthcare access improves globally, the demand for fibrinogen products grows, driving the need for effective distribution strategies.

How do reimbursement policies affect the downstream phase of the fibrinogen market?

Reimbursement policies are crucial in determining the affordability and accessibility of fibrinogen treatments. In regions with favorable reimbursement conditions, access to fibrinogen therapies is higher, while in areas with restrictive policies, the demand may be limited despite medical need.

Chapter 1, to describe Fibrinogen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fibrinogen, with price, sales, revenue and global market share of Fibrinogen from 2018 to 2023.
Chapter 3, the Fibrinogen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fibrinogen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Fibrinogen market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fibrinogen.
Chapter 14 and 15, to describe Fibrinogen sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Fibrinogen
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Fibrinogen Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Human Fibrinogen
       1.3.3 Animal Fibrinogen
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Fibrinogen Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Congenital Fibrinogen Deficiency
       1.4.3 Surgical Procedures
       1.4.4 Others
   1.5 Global Fibrinogen Market Size & Forecast
       1.5.1 Global Fibrinogen Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Fibrinogen Sales Quantity (2018-2029)
       1.5.3 Global Fibrinogen Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 CSL Behring
       2.1.1 CSL Behring Details
       2.1.2 CSL Behring Major Business
       2.1.3 CSL Behring Fibrinogen Product and Services
       2.1.4 CSL Behring Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 CSL Behring Recent Developments/Updates
   2.2 LFB Group
       2.2.1 LFB Group Details
       2.2.2 LFB Group Major Business
       2.2.3 LFB Group Fibrinogen Product and Services
       2.2.4 LFB Group Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 LFB Group Recent Developments/Updates
   2.3 Shanghai RAAS Blood Products
       2.3.1 Shanghai RAAS Blood Products Details
       2.3.2 Shanghai RAAS Blood Products Major Business
       2.3.3 Shanghai RAAS Blood Products Fibrinogen Product and Services
       2.3.4 Shanghai RAAS Blood Products Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
   2.4 Jiangxi Boya Bio-Pharmaceutical
       2.4.1 Jiangxi Boya Bio-Pharmaceutical Details
       2.4.2 Jiangxi Boya Bio-Pharmaceutical Major Business
       2.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product and Services
       2.4.4 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
   2.5 Hualan Biological Engineering
       2.5.1 Hualan Biological Engineering Details
       2.5.2 Hualan Biological Engineering Major Business
       2.5.3 Hualan Biological Engineering Fibrinogen Product and Services
       2.5.4 Hualan Biological Engineering Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Hualan Biological Engineering Recent Developments/Updates
   2.6 Harbin Pacific Biopharmaceutical
       2.6.1 Harbin Pacific Biopharmaceutical Details
       2.6.2 Harbin Pacific Biopharmaceutical Major Business
       2.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Product and Services
       2.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
   2.7 GREEN CROSS
       2.7.1 GREEN CROSS Details
       2.7.2 GREEN CROSS Major Business
       2.7.3 GREEN CROSS Fibrinogen Product and Services
       2.7.4 GREEN CROSS Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 GREEN CROSS Recent Developments/Updates
   2.8 Shanghai XinXing Medical
       2.8.1 Shanghai XinXing Medical Details
       2.8.2 Shanghai XinXing Medical Major Business
       2.8.3 Shanghai XinXing Medical Fibrinogen Product and Services
       2.8.4 Shanghai XinXing Medical Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Shanghai XinXing Medical Recent Developments/Updates
   2.9 Taibang Biologic
       2.9.1 Taibang Biologic Details
       2.9.2 Taibang Biologic Major Business
       2.9.3 Taibang Biologic Fibrinogen Product and Services
       2.9.4 Taibang Biologic Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Taibang Biologic Recent Developments/Updates
   2.10 Octapharma
       2.10.1 Octapharma Details
       2.10.2 Octapharma Major Business
       2.10.3 Octapharma Fibrinogen Product and Services
       2.10.4 Octapharma Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Octapharma Recent Developments/Updates

3 Competitive Environment: Fibrinogen by Manufacturer

   3.1 Global Fibrinogen Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Fibrinogen Revenue by Manufacturer (2018-2023)
   3.3 Global Fibrinogen Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Fibrinogen by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Fibrinogen Manufacturer Market Share in 2022
       3.4.2 Top 6 Fibrinogen Manufacturer Market Share in 2022
   3.5 Fibrinogen Market: Overall Company Footprint Analysis
       3.5.1 Fibrinogen Market: Region Footprint
       3.5.2 Fibrinogen Market: Company Product Type Footprint
       3.5.3 Fibrinogen Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Fibrinogen Market Size by Region
       4.1.1 Global Fibrinogen Sales Quantity by Region (2018-2029)
       4.1.2 Global Fibrinogen Consumption Value by Region (2018-2029)
       4.1.3 Global Fibrinogen Average Price by Region (2018-2029)
   4.2 North America Fibrinogen Consumption Value (2018-2029)
   4.3 Europe Fibrinogen Consumption Value (2018-2029)
   4.4 Asia-Pacific Fibrinogen Consumption Value (2018-2029)
   4.5 South America Fibrinogen Consumption Value (2018-2029)
   4.6 Middle East and Africa Fibrinogen Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Fibrinogen Sales Quantity by Type (2018-2029)
   5.2 Global Fibrinogen Consumption Value by Type (2018-2029)
   5.3 Global Fibrinogen Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Fibrinogen Sales Quantity by Application (2018-2029)
   6.2 Global Fibrinogen Consumption Value by Application (2018-2029)
   6.3 Global Fibrinogen Average Price by Application (2018-2029)

7 North America

   7.1 North America Fibrinogen Sales Quantity by Type (2018-2029)
   7.2 North America Fibrinogen Sales Quantity by Application (2018-2029)
   7.3 North America Fibrinogen Market Size by Country
       7.3.1 North America Fibrinogen Sales Quantity by Country (2018-2029)
       7.3.2 North America Fibrinogen Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Fibrinogen Sales Quantity by Type (2018-2029)
   8.2 Europe Fibrinogen Sales Quantity by Application (2018-2029)
   8.3 Europe Fibrinogen Market Size by Country
       8.3.1 Europe Fibrinogen Sales Quantity by Country (2018-2029)
       8.3.2 Europe Fibrinogen Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Fibrinogen Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Fibrinogen Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Fibrinogen Market Size by Region
       9.3.1 Asia-Pacific Fibrinogen Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Fibrinogen Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Fibrinogen Sales Quantity by Type (2018-2029)
   10.2 South America Fibrinogen Sales Quantity by Application (2018-2029)
   10.3 South America Fibrinogen Market Size by Country
       10.3.1 South America Fibrinogen Sales Quantity by Country (2018-2029)
       10.3.2 South America Fibrinogen Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Fibrinogen Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Fibrinogen Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Fibrinogen Market Size by Country
       11.3.1 Middle East & Africa Fibrinogen Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Fibrinogen Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Fibrinogen Market Drivers
   12.2 Fibrinogen Market Restraints
   12.3 Fibrinogen Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Fibrinogen and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Fibrinogen
   13.3 Fibrinogen Production Process
   13.4 Fibrinogen Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Fibrinogen Typical Distributors
   14.3 Fibrinogen Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Fibrinogen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Fibrinogen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
   Table 4. CSL Behring Major Business
   Table 5. CSL Behring Fibrinogen Product and Services
   Table 6. CSL Behring Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. CSL Behring Recent Developments/Updates
   Table 8. LFB Group Basic Information, Manufacturing Base and Competitors
   Table 9. LFB Group Major Business
   Table 10. LFB Group Fibrinogen Product and Services
   Table 11. LFB Group Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. LFB Group Recent Developments/Updates
   Table 13. Shanghai RAAS Blood Products Basic Information, Manufacturing Base and Competitors
   Table 14. Shanghai RAAS Blood Products Major Business
   Table 15. Shanghai RAAS Blood Products Fibrinogen Product and Services
   Table 16. Shanghai RAAS Blood Products Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Shanghai RAAS Blood Products Recent Developments/Updates
   Table 18. Jiangxi Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
   Table 19. Jiangxi Boya Bio-Pharmaceutical Major Business
   Table 20. Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product and Services
   Table 21. Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
   Table 23. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
   Table 24. Hualan Biological Engineering Major Business
   Table 25. Hualan Biological Engineering Fibrinogen Product and Services
   Table 26. Hualan Biological Engineering Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Hualan Biological Engineering Recent Developments/Updates
   Table 28. Harbin Pacific Biopharmaceutical Basic Information, Manufacturing Base and Competitors
   Table 29. Harbin Pacific Biopharmaceutical Major Business
   Table 30. Harbin Pacific Biopharmaceutical Fibrinogen Product and Services
   Table 31. Harbin Pacific Biopharmaceutical Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Harbin Pacific Biopharmaceutical Recent Developments/Updates
   Table 33. GREEN CROSS Basic Information, Manufacturing Base and Competitors
   Table 34. GREEN CROSS Major Business
   Table 35. GREEN CROSS Fibrinogen Product and Services
   Table 36. GREEN CROSS Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. GREEN CROSS Recent Developments/Updates
   Table 38. Shanghai XinXing Medical Basic Information, Manufacturing Base and Competitors
   Table 39. Shanghai XinXing Medical Major Business
   Table 40. Shanghai XinXing Medical Fibrinogen Product and Services
   Table 41. Shanghai XinXing Medical Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Shanghai XinXing Medical Recent Developments/Updates
   Table 43. Taibang Biologic Basic Information, Manufacturing Base and Competitors
   Table 44. Taibang Biologic Major Business
   Table 45. Taibang Biologic Fibrinogen Product and Services
   Table 46. Taibang Biologic Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Taibang Biologic Recent Developments/Updates
   Table 48. Octapharma Basic Information, Manufacturing Base and Competitors
   Table 49. Octapharma Major Business
   Table 50. Octapharma Fibrinogen Product and Services
   Table 51. Octapharma Fibrinogen Sales Quantity (Kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Octapharma Recent Developments/Updates
   Table 53. Global Fibrinogen Sales Quantity by Manufacturer (2018-2023) & (Kg)
   Table 54. Global Fibrinogen Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 55. Global Fibrinogen Average Price by Manufacturer (2018-2023) & (US$/g)
   Table 56. Market Position of Manufacturers in Fibrinogen, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 57. Head Office and Fibrinogen Production Site of Key Manufacturer
   Table 58. Fibrinogen Market: Company Product Type Footprint
   Table 59. Fibrinogen Market: Company Product Application Footprint
   Table 60. Fibrinogen New Market Entrants and Barriers to Market Entry
   Table 61. Fibrinogen Mergers, Acquisition, Agreements, and Collaborations
   Table 62. Global Fibrinogen Sales Quantity by Region (2018-2023) & (Kg)
   Table 63. Global Fibrinogen Sales Quantity by Region (2024-2029) & (Kg)
   Table 64. Global Fibrinogen Consumption Value by Region (2018-2023) & (USD Million)
   Table 65. Global Fibrinogen Consumption Value by Region (2024-2029) & (USD Million)
   Table 66. Global Fibrinogen Average Price by Region (2018-2023) & (US$/g)
   Table 67. Global Fibrinogen Average Price by Region (2024-2029) & (US$/g)
   Table 68. Global Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 69. Global Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 70. Global Fibrinogen Consumption Value by Type (2018-2023) & (USD Million)
   Table 71. Global Fibrinogen Consumption Value by Type (2024-2029) & (USD Million)
   Table 72. Global Fibrinogen Average Price by Type (2018-2023) & (US$/g)
   Table 73. Global Fibrinogen Average Price by Type (2024-2029) & (US$/g)
   Table 74. Global Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 75. Global Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 76. Global Fibrinogen Consumption Value by Application (2018-2023) & (USD Million)
   Table 77. Global Fibrinogen Consumption Value by Application (2024-2029) & (USD Million)
   Table 78. Global Fibrinogen Average Price by Application (2018-2023) & (US$/g)
   Table 79. Global Fibrinogen Average Price by Application (2024-2029) & (US$/g)
   Table 80. North America Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 81. North America Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 82. North America Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 83. North America Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 84. North America Fibrinogen Sales Quantity by Country (2018-2023) & (Kg)
   Table 85. North America Fibrinogen Sales Quantity by Country (2024-2029) & (Kg)
   Table 86. North America Fibrinogen Consumption Value by Country (2018-2023) & (USD Million)
   Table 87. North America Fibrinogen Consumption Value by Country (2024-2029) & (USD Million)
   Table 88. Europe Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 89. Europe Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 90. Europe Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 91. Europe Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 92. Europe Fibrinogen Sales Quantity by Country (2018-2023) & (Kg)
   Table 93. Europe Fibrinogen Sales Quantity by Country (2024-2029) & (Kg)
   Table 94. Europe Fibrinogen Consumption Value by Country (2018-2023) & (USD Million)
   Table 95. Europe Fibrinogen Consumption Value by Country (2024-2029) & (USD Million)
   Table 96. Asia-Pacific Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 97. Asia-Pacific Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 98. Asia-Pacific Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 99. Asia-Pacific Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 100. Asia-Pacific Fibrinogen Sales Quantity by Region (2018-2023) & (Kg)
   Table 101. Asia-Pacific Fibrinogen Sales Quantity by Region (2024-2029) & (Kg)
   Table 102. Asia-Pacific Fibrinogen Consumption Value by Region (2018-2023) & (USD Million)
   Table 103. Asia-Pacific Fibrinogen Consumption Value by Region (2024-2029) & (USD Million)
   Table 104. South America Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 105. South America Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 106. South America Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 107. South America Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 108. South America Fibrinogen Sales Quantity by Country (2018-2023) & (Kg)
   Table 109. South America Fibrinogen Sales Quantity by Country (2024-2029) & (Kg)
   Table 110. South America Fibrinogen Consumption Value by Country (2018-2023) & (USD Million)
   Table 111. South America Fibrinogen Consumption Value by Country (2024-2029) & (USD Million)
   Table 112. Middle East & Africa Fibrinogen Sales Quantity by Type (2018-2023) & (Kg)
   Table 113. Middle East & Africa Fibrinogen Sales Quantity by Type (2024-2029) & (Kg)
   Table 114. Middle East & Africa Fibrinogen Sales Quantity by Application (2018-2023) & (Kg)
   Table 115. Middle East & Africa Fibrinogen Sales Quantity by Application (2024-2029) & (Kg)
   Table 116. Middle East & Africa Fibrinogen Sales Quantity by Region (2018-2023) & (Kg)
   Table 117. Middle East & Africa Fibrinogen Sales Quantity by Region (2024-2029) & (Kg)
   Table 118. Middle East & Africa Fibrinogen Consumption Value by Region (2018-2023) & (USD Million)
   Table 119. Middle East & Africa Fibrinogen Consumption Value by Region (2024-2029) & (USD Million)
   Table 120. Fibrinogen Raw Material
   Table 121. Key Manufacturers of Fibrinogen Raw Materials
   Table 122. Fibrinogen Typical Distributors
   Table 123. Fibrinogen Typical Customers

List of Figures

   Figure 1. Fibrinogen Picture
   Figure 2. Global Fibrinogen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Fibrinogen Consumption Value Market Share by Type in 2022
   Figure 4. Human Fibrinogen Examples
   Figure 5. Animal Fibrinogen Examples
   Figure 6. Global Fibrinogen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Fibrinogen Consumption Value Market Share by Application in 2022
   Figure 8. Congenital Fibrinogen Deficiency Examples
   Figure 9. Surgical Procedures Examples
   Figure 10. Others Examples
   Figure 11. Global Fibrinogen Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global Fibrinogen Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Fibrinogen Sales Quantity (2018-2029) & (Kg)
   Figure 14. Global Fibrinogen Average Price (2018-2029) & (US$/g)
   Figure 15. Global Fibrinogen Sales Quantity Market Share by Manufacturer in 2022
   Figure 16. Global Fibrinogen Consumption Value Market Share by Manufacturer in 2022
   Figure 17. Producer Shipments of Fibrinogen by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 18. Top 3 Fibrinogen Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Top 6 Fibrinogen Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Global Fibrinogen Sales Quantity Market Share by Region (2018-2029)
   Figure 21. Global Fibrinogen Consumption Value Market Share by Region (2018-2029)
   Figure 22. North America Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 23. Europe Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 24. Asia-Pacific Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 25. South America Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 26. Middle East & Africa Fibrinogen Consumption Value (2018-2029) & (USD Million)
   Figure 27. Global Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 28. Global Fibrinogen Consumption Value Market Share by Type (2018-2029)
   Figure 29. Global Fibrinogen Average Price by Type (2018-2029) & (US$/g)
   Figure 30. Global Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 31. Global Fibrinogen Consumption Value Market Share by Application (2018-2029)
   Figure 32. Global Fibrinogen Average Price by Application (2018-2029) & (US$/g)
   Figure 33. North America Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 34. North America Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 35. North America Fibrinogen Sales Quantity Market Share by Country (2018-2029)
   Figure 36. North America Fibrinogen Consumption Value Market Share by Country (2018-2029)
   Figure 37. United States Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Canada Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Mexico Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Europe Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 41. Europe Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 42. Europe Fibrinogen Sales Quantity Market Share by Country (2018-2029)
   Figure 43. Europe Fibrinogen Consumption Value Market Share by Country (2018-2029)
   Figure 44. Germany Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. France Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. United Kingdom Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Russia Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Italy Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Asia-Pacific Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 50. Asia-Pacific Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 51. Asia-Pacific Fibrinogen Sales Quantity Market Share by Region (2018-2029)
   Figure 52. Asia-Pacific Fibrinogen Consumption Value Market Share by Region (2018-2029)
   Figure 53. China Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Japan Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Korea Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. India Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Southeast Asia Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Australia Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. South America Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 60. South America Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 61. South America Fibrinogen Sales Quantity Market Share by Country (2018-2029)
   Figure 62. South America Fibrinogen Consumption Value Market Share by Country (2018-2029)
   Figure 63. Brazil Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Argentina Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Middle East & Africa Fibrinogen Sales Quantity Market Share by Type (2018-2029)
   Figure 66. Middle East & Africa Fibrinogen Sales Quantity Market Share by Application (2018-2029)
   Figure 67. Middle East & Africa Fibrinogen Sales Quantity Market Share by Region (2018-2029)
   Figure 68. Middle East & Africa Fibrinogen Consumption Value Market Share by Region (2018-2029)
   Figure 69. Turkey Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Egypt Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Saudi Arabia Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. South Africa Fibrinogen Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Fibrinogen Market Drivers
   Figure 74. Fibrinogen Market Restraints
   Figure 75. Fibrinogen Market Trends
   Figure 76. Porters Five Forces Analysis
   Figure 77. Manufacturing Cost Structure Analysis of Fibrinogen in 2022
   Figure 78. Manufacturing Process Analysis of Fibrinogen
   Figure 79. Fibrinogen Industrial Chain
   Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 81. Direct Channel Pros & Cons
   Figure 82. Indirect Channel Pros & Cons
   Figure 83. Methodology
   Figure 84. Research Process and Data Source